Showing results (151-160 of 242) with videos related to
Sort By:
Pageof 25
Oncogene|October 22, 2008
Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitorsJ R Smith, P A Clarke, E de Billy, et al.British Journal of Cancer|June 1, 1993
Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell linesH M Coley, W B Amos, P R Twentyman, et al.The British Journal of Radiology|February 1, 1986
A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokineticsJ T Roberts, N M Bleehen, M I Walton, et al.British Journal of Cancer|December 1, 1978
Monitoring salivary misonidazole in man: a possible alternative to plasma monitoringP Workman, C R Wiltshire, P N Plowman, et al.British Journal of Cancer|April 1, 1980
Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouseD J Honess, P Workman, J E Morgan, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell linesJ A Plumb, M Gerritsen, R Milroy, et al.British Journal of Cancer|August 1, 1979
The penetration of misonidazole into spontaneous canine tumoursR A White, P Workman, L N Owen, et al.Journal of Microscopy|June 1, 1992
The use of parallel EEL spectral imaging and elemental mapping in the rapid assessment of anti-cancer drug localizationI M Huxham, M N Gaze, P Workman, et al.British Journal of Cancer|November 17, 2001
Measuring changes in human tumour vasculature in response to therapy using functional imaging techniquesH Anderson, P Price, M Blomley, et al.Cancer Research|May 19, 2001
Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosisI Hostein, D Robertson, F DiStefano, et al.Pageof 25